The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid prescription fills by one third, according to goals released Friday for its National Drug Control Strategy. Among other goals for 2022, the office aims to have 20 percent of specialty treatment facilities providing medication-assisted treatment, 10 percent of practitioners certified to prescribe and dispense buprenorphine for opioid use disorder, and 72 percent of federal prescribers complete continuing education on opioid best practices and clinical guidelines. It also aims to increase to 30 the number of states integrating electronic health records with their prescription drug monitoring programs. The office released its National Drug Control Strategy in February to guide federal efforts to reduce the availability and use of illicit drugs and barriers to substance use disorder treatment.

Related News Articles

Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
Mallinckrodt Pharmaceuticals today announced an agreement in principle on a settlement to resolve all opioid-related claims against the company in…
Headline
Public and private entities can apply for $1 million grants for a three-year period to enhance or expand opioid and other substance use disorder services in…
Headline
Rep. Vicky Hartzler, R-Mo., House Energy and Commerce Committee Ranking Member Greg Walden, R-Ore., and other Republicans on the committee last week asked the…
Headline
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing to highlight how federal funds have helped states combat…